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      BSTRACT
Dourine is a contagious disease caused by Trypanosoma equiperdum that is transmitted 
directly from animal to animal during coitus. Dourine is known as an important disease in many 
countries, and it threatens equidae worldwide. It is reported to be widespread in South America, 
Eastern Europe, Russia, Mongolia, Namibia and Ethiopia. The disease can be carried to various 
parts of the world through the transportation of infected animals and semen. Since knowledge 
of the prepatent infectiousness of a recently infected animal is lacking, introduction of the 
disease is in principle an ever-present threat. Definitive diagnosis depends on the identification 
of the parasite by means of direct microscopy. This is rarely possible in practice and therefore, 
diagnosis in the field is based on the observation of typical clinical signs, together with serological 
tests. This paper is an endeavour to review briefly and compile information on the appearance 
and importance of Dourine in terms of its epidemiological and clinical features, as well as on its 
diagnosis, treatment and prognosis.
SAMENVATTING
Dourine is een infectieuze en venerisch overdraagbare ziekte bij paarden die veroorzaakt wordt 
door Trypanosoma equiperdum. Deze aandoening is endemisch in Zuid-Amerika, Mongolië, Namibië, 
Ethiopië, Rusland en Oost-Europa en heeft een negatieve invloed op de gezondheid van de betreffende 
paardenpopulaties. 
De ziekteverspreiding kan bespoedigd worden door het transport van geïnfecteerde dieren en 
sperma. De huidige kennis over de infectiviteit van het agens tijdens  de prepatentperiode bij besmette 
dieren is minimaal. Aldus kan Dourine in landen verspreid worden die voorheen vrij waren van de 
ziekte. De eigenlijke diagnose is gebaseerd op de identificatie van de parasiet. Gezien dit in de praktijk 
meestal niet haalbaar is, wordt het klinisch beeld samen met niet-specifieke serologische testen gebruikt 
om de ziekte vast te stellen. In dit artikel wordt een overzicht gegeven over het belang van Dourine 
bij het paard. Verder worden de epidemiologie, het klinische ziektebeeld alsook de mogelijkheden van 
diagnostiek en behandeling besproken. 
A
  Review 
INTRODUCTION
Trypanosomosis is a parasitic disease caused by dif-
ferent species of flagellated protozoa belonging to the 
genus Trypanosoma, which inhabit the blood and var-
ious body tissues and fluids of vertebrate hosts. Non-
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result from infection by Trypanosoma (T). vivax, T. 
evansi and T. equiperdum (Touratier, 2000). However, 
the extent of tissue invasion varies among the differ-
ent parasite species (Igbokwe, 1996; Radostitis et al., 
1996). The disease is frequently fatal and is a serious 
constraint to agricultural production in large parts of 
sub-Saharan Africa, exhibiting direct impact on live-
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stock productivity, livestock management and human 
settlement, and indirect impact on crop agriculture 
(Swallow, 2000).
Trypanosoma (T.) equiperdum differs substantially 
from other trypanosome species that are transmitted 
by invertebrate vectors. T. equiperdum is transmitted 
venereally directly from one infected horse to another. 
The trypanosomes, which are present in the seminal 
fluid and mucous membranes of the genitalia of the 
donor animal, are transferred to the recipient during 
sexual intercourse. Moreover, T. equiperdum further 
differs from other trypanosomes in that it is primarily 
a tissue parasite that rarely invades the blood (Bar-
rowman 1976; Vulpiani et al., 2013; OIE, 2013). 
Dourine caused by T. equiperdum is characterized 
mainly by fever, edematous swelling of the genitalia, 
cutaneous plaques and eruptions and neurological 
signs including incoordination, paralysis, ocular le-
sions (such as conjunctivitis, keratitis and mild cor-
neal opacity), anemia and progressive emaciation 
(Barrowman 1976; Luckins 1994, Vulpiani et al., 
2013). Clinical signs related to Dourine have been 
documented to be often obvious, but final diagnosis 
requires demonstration of the parasite through sero-
logical and molecular tests (OIE, 2013).
Among the various species of Trypanosoma, T. 
equiperdum and T. evansi infection in equines cause 
similar signs. In view of this fact, the actual course 
of the disease caused by these two trypanosome spe-
cies was uncertain due to the close similarity in their 
ultrastructure, genetic makeup and antigenic nature, 
as has been demonstrated by the fact that the two spe-
cies have shown similar genetic and antigenic expres-
sion (Touatier, 2000; Verloo et al., 2001; Claes et al., 
2003a,b). However, recent findings of whole genome 
analysis of T. evansi and T. equiperdum provided new 
insights of their distinction and their relation with the 
different T. brucei subspecies (Birhanu et al., 2016; 
Cuypers et al., 2017). Both are evolved from T. brucei 
but with different geographical origins. The T. evansi 
genomes are related to the T. brucei genomes from 
Western Africa, whereas the T. equiperdum genomes 
are related to the T. brucei genomes from Eastern Af-
rica (Carnes et al., 2015; Cuypers et al., 2017). 
Currently, there are fragmented reports and find-
ings about the disease in its occurrence, clinical signs, 
efficacy of treatment, etc. Therefore, the objective of 
this paper is to review and compile information on the 
appearance and importance of Dourine in terms of its 
epidemiological and clinical features, as well as on its 
diagnosis, treatment and prognosis.
APPEARANCE AND IMPORTANCE OF DOU-
RINE
Dourine is known in most countries of the world 
as a notifiable disease (OIE, 2013) and it threatens 
equidae around the globe. The disease is reported 
to be widespread in South America (Samper and Ti-
bary, 2006; Sellon and Long, 2007; Perrone et al., 
2009; Sanchez et al., 2015), Mongolia (Clausen et 
al., 2003), Namibia (Kumba et al., 2002), Eastern Eu-
rope (Discontools, 2011) and Ethiopia (Alemu et al., 
1997; Clausen et al., 1999; Fikru et al., 2010; Hagos 
et al., 2010a,b). Recently, the disease has also been 
observed in the south of Europe, in Italy (Scacchia et 
al., 2011; Pascucci et al., 2013).
The disease can be carried to various parts of the 
world through the transportation of infected stallions, 
mares, donkeys and semen. The spread of the caus-
al agent by AI has not been confirmed; however, it 
could potentially occur since T. equiperdum is present 
in seminal fluid and genital tissues (Lelli et al., 2012). 
Besides venereal transmission, close contact between 
mare and foals, e.g. during nursing (Brun et al., 1998; 
Lelli et al., 2012), contaminated equipment, such as 
an artificial vagina and breeding phantom, or conta-
minated personnel can also cause transmission (Met-
calf, 2001; Samper and Tibary, 2006).
Today, despite the numerous benefits of shipping 
semen internationally, some serious threats remain 
unclear when the semen is contaminated with a com-
municable disease. Import regulations to prevent en-
try of the disease from endemic countries will require 
a negative Dourine test for horses and horse gametes. 
The current regulations vary between countries (IH-
SES, 2007; Calistri et al., 2013), which makes it dif-
ficult to comply with all of them when dealing for 
instance with cryopreserved semen. The import regu-
lations vary from requiring only a permit for importa-
tion to several months of quarantine of the stallion. 
Due to the lack of knowledge of the prepatent infec-
tiousness of the semen of recently infected animals, 
the transmission of disease through the transport of 
either the breeding stock or their gametes is a threat 
for the equine industry (Metcalf, 2001).
Although Dourine has a high mortality rate of up 
to 50%, some infected animals have been observed 
to recover spontaneously (Equimed, 2009; Ricketts et 
al., 2011; OIE, 2013). So far, there has been no known 
natural reservoir of the parasite other than infected 
equids. Donkeys and mules are more resistant than 
horses and may therefore remain unapparent carri-
ers, in which the disease may often pass unperceived, 
even though their semen and vaginal secretions con-
tain the infective trypanosomes (OIE, 2013).
ETIOLOGY
Trypanosomes are flagellated and elongated spin-
dle-shaped protozoa with an average length of 20-30 
μm and a width of 1.5 to 3.5 μm. The trypanosome 
cell has a blunted posterior end and a free flagellum at 
the anterior end (Matthews, 2005) (Figure 1).
The name T. equiperdum was postulated by Doflein 
in 1901 as cited in OIE (2013). T. equiperdum is a 
member of the non-tsetse-transmitted trypanosome 
group. The trypanosomes, which are strictly parasi-
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tic, are flagellar protozoa that belong to the phylum 
of Sarcomastigophora, the order of Kinetoplastidae, 
the family of Trypanosomatidae and the genus of Try-
panosoma, under the Salivarian group. The subgenus 
Trypanozoon includes the pathogenic species T. evan-
si, T. brucei and T. equiperdum. T. brucei is further 
divided into three subspecies: the animal pathogen 
T. b. brucei (ruminants, equines), and the two human 
pathogens responsible for human sleeping sickness, 
T. b. gambiense and T. b. rhodesiense (Hoare, 1972). 
T. equiperdum has recently come to be considered a 
subspecies of T. brucei based on molecular analysis 
(Claes et al., 2003b; Li et al., 2005, Lun et al., 2010; 
Schnaufer, 2010; Carnes et al., 2015; Wen et al., 2016).
Kinetoplastid flagellates contain their eponym kine- 
toplast DNA (kDNA), consisting of two types of inter- 
locked circular DNA molecules: dozens of maxi- 
circles and thousands of minicircles. The maxicircles 
have typical mitochondrial genes, most of which are 
translatable only after RNA editing. The minicircles 
encode guide RNA’s, which are required for de-
crypting the maxicircle transcripts (Lai et al., 2008). 
T. brucei is a kinetoplastid trypanosome whereas T. 
evansi and T. equiperdum are dyskinetoplastic try-
panosomes. T. evansi lack the maxicircle genes, but T. 
equiperdum does have, although with major deletions 
of some genes. So far, no akinetoplastic (lacking all 
kDNA) T. equiperdum have been observed (Birhanu 
et al., 2016). Two biological features differentiate T. 
evansi and T. equiperdum from the T. brucei. First, 
they do not use tsetse flies as the vector for transmis-
sion, since T. evansi is transmitted by biting flies and 
T. equiperdum by sexual contact (Desquesnes et al., 
2013; Brun et al., 1998). Secondly, T. evansi and T. 
equiperdum are dyskinetoplastic, lacking part of or all 
(akinetoplastic) of their kDNA (Lai et al., 2008). Par-
tial dyskinetoplastidy or total akinetoplastidy locks 
the trypanosome in the blood stream form trypamas-
tigotes in the host, and transmission between verte-
brates becomes purely mechanical, without further 
development in a vector (Bringuard et al., 2006). 
Trypanosomes of subspecies T. equiperdum are 
rarely observed in the bloodstream of the host because 
they are normally localized in the capillaries of the 
mucous membranes of the urogenital tract (Brun et 
al., 1998). However, a few trypanosomes occasion-
ally appear in the peripheral blood of animals (Brun et 
al., 1998; Fikru et al., 2010; Hagos et al., 2010c). The 
fact that foals have been found to be infected with T. 
equiperdum may indicate that the parasite can also be 
directly transmitted through udder lesions or milk, or 
during passage through the birth canal upon parturi-
tion (Schultz, 1935; Wang, 1988; Brun et al., 1998). 
Vertical transmission of T. evansi has already been re-
ported in camels (Narnaware et al., 2016).
The true T. equiperdum strains successfully iso-
lated and available for various studies are OVI, BoTat 
1.1, Dodola 940 and 943 and the Mongolian isolates 
(IVM-t1) (OIE 2013; Birhanu et al., 2016, Suganuma 
et al., 2016).
Figure 1. Dourine causing agent (T. equipe-
rdum). Diff quick stain of thin blood smear at 
x 1000 microscopy from experimentally infected 
and Dourine diseased horses (A). Fine structure 
of the protozoan parasite Typanosoma evansi, as 
revealed by transmission electron microscopy of 
thin sections (Yaeger R. G. (1996)). 
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CLINICAL SIGNS
Clinical symptoms, although not pathognomonic, 
can be of great help in diagnosing the disease in en-
demic areas. The presence of edematous swellings of 
the external genitalia, the development of plaques of 
the skin, and the appearance of nervous signs such as 
ataxia and incoordination are highly indicative for the 
disease (Vulpiani et al., 2013). 
Substantial weight loss leading to severe emacia-
tion, weakness and a generally poor condition has 
been reported in naturally infected as well as experi-
mentally infected horses (Vulpiani et al., 2013). Ha-
gos et al. (2010a, c) also reported marked muscular 
atrophy in the gluteal region, emaciation, weakness 
and poor body condition as important clinical signs 
in horses. However, the vulvar or preputial lesions of 
Dourine might be difficult to clinically differentiate 
from other diseases such as Equine Coital Exanthema 
(EHV3) in the early stages and in latent cases (Bar-
rowman, 1976). Equine Herpes Virus (EHV3) in-
fection is manifested by the appearance of vesicles, 
ulcers and depigmented spots on the vaginal mucous 
membrane (Blanchard et al., 1992; Studdert, 1996; 
Allen and Umphenour, 2004), which is similar to the 
genital form of Dourine. By contrast, however, EHV3 
is self-limited and is not accompanied by emaciation, 
ataxia or incoordination. 
Lesions in the genitalia are documented to be the 
first symptoms after T. equiperdum infection. In stal-
lions, moderate edema of the scrotum and preputial 
sheath (Figures 2 E and F) is seen, accompanied by 
both preputial and urethral purulent discharge. In 
mares, edema of the vulva, accompanied by ulcers 
along the rim of the vulva, vaginal discharge mainly of 
the mucopurulent type with foul odour, and edema of 
the mammary gland and cloudy off-white mammary 
secretions have been documented as the prominent 
signs in the genital form of the disease. Later in the 
progression of the disease, edema of all ventral body 
parts, and cutaneous plaques all over the body can be 
seen. At this stage, the edematous plaques, especially 
on the genitalia, frequently ulcerate and become de-
pigmented scars (Hagos et al., 2010a; Vulpiani et al., 
2013) (Figure 2 D). This depigmentation has been in-
dicated to be due to severe dermatitis with hydropic 
degeneration and necrosis of the keratinocytes and 
necrosis of basal cells including the melanocytes with 
excess free melanin pigment within the epidermis 
(Gizaw et al., 2017).
The next stage of Dourine is characterized by pro-
gressive anemia, with or without fever, and nervous 
disorders, mainly manifested as paraplegia and para-
lysis of the hind limbs, showing severe muscle atrophy 
and emaciation before death (Hoare, 1972; Stephen, 
1986) (Figures 2 A, B and C).
Nervous signs such as stiffness, weakness, lame-
ness in one or more hind legs, staggering, lack of co-
ordination, inability to stand upright after prolonged 
sternal or lateral recumbence, ataxia and facial paraly-
sis have also been reported by Hagos et al. (2010a) 
and Vulpiani et al. (2013). 
DIAGNOSIS
Diagnosis has to be based on demonstrating the 
presence of the parasite itself or indirectly by anti-
body detection. However, there is no defined serologi-
cal assay for T. equiperdum nor molecular markers 
Figure 2. Symptomatology of Dourine infected horses. A. and B. Mare with weight loss and hind quarter paralysis. C. 
Stallion with hind quarter paralysis. D. Mare with depigmented scar at the vulva. E. and F. Swelling at the prepuce 
and scrotum from experimentally infected horses with T. equiperdum (mares are infected by artificial insemination 
after spiking the semen by T. equiperdum Dodola 943 and stallions are infected by the blood transfusion from these 
mares via intra venous route. Ethical clearance for this experiment was obtained from the Ethical Review Committee 
of Addis Ababa University College of Veterinary Medicine and Agriculture to use animals for experimentation (Ref. 
No: VM/ERC/004/07/015).  
A B C
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that can be used for clinical use so far. The clinical 
signs and gross lesions in diseased animals are sug-
gestive, but cannot always be identified with certainty, 
especially in the early stages or in latent cases, and in 
cases of surra due to T. evansi, which exhibits simi-
lar clinical signs (OIE, 2013). Other conditions, such 
as equine coital exanthema or chronic irritation (e.g. 
urine scalding), might cause some similar clinical fea-
tures (Blanchard et al., 1992; Studdert, 1996; Allen 
and Umphenour, 2004). 
Differentiation between T. equiperdum and T. 
evansi based on parasite morphology is difficult in 
areas where both organisms are found (Brun et al., 
1998; Sanchaz et al., 2015; Suganuma et al., 2016). 
So far, there are no defined serological assays for the 
true T. equiperdum and also no molecular markers for 
clinical use. Previously, Claes et al. (2004) and Fikru 
et al. (2010) used a PCR to amplify a portion of the 
RoTat 1.2. VSG coding gene in order to detect T. equi-
perdum. More recently, it has been shown that RoTat 
1.2 VSG is not present on T. equiperdum (Birhanu et 
al., 2016), thus making previously reported findings 
equivocal. 
Direct diagnosis: parasitological techniques
Wet, thick blood films can be examined micro-
scopically (x400) under a coverslip. Detection of Try-
panosomes moving in between the erythrocytes is a 
simple, although non-species specific, parasitological 
test. However, with a detection limit as high as 10,000 
trypanosomes/ml, the technique has a very low sensi-
tivity. Giemsa or stained thin blood films have a simi-
larly low sensitivity. The sensitivity can be increased 
by applying concentration techniques such as used in 
the Woo test (Woo, 1970). This test includes a micro-
centrifugation of 50µl whole blood at 3000 g for 5 
minutes. Subsequently, the capillary tubes are mount-
ed in a special holder and the buffy coat is examined 
microscopically at magnification of ×100 to look for 
live parasites (Woo, 1970; Reid et al. 2001; Fikru et 
al., 2010). On microscopic evaluation, T. equiperdum 
and T. evansi cannot be differentiated from one an-
other, a fact which makes the test less reliable in areas 
where both organisms are prevalent (OIE, 2012). 
Immunohistochemistry and immunofluorescence
A more recent study managed to identify and lo-
calize trypanosome antigen directly in the tissue by 
immunochemistry, using Mayer’s hematoxylin, in 
addition to an immunofluorescence staining, using 
diamidin phenylindole (DAPI) (Pasucci et al., 2013).
Animal inoculation
Mice, rats, rabbits and dogs are susceptible to 
laboratory adapted T. equiperdum strains (Brun et 
al., 1998; Claes et al., 2005; Akhmetova, et al. 2016). 
However, beside the animal welfare issues, it is of-
ten difficult to obtain a first passage from samples 
obtained from the host, and animal inoculation is of 
little use as a routine method of diagnosis. 
Blood from suspected animals can be used as in-
oculants for laboratory rodents. Under laboratory con-
ditions, dogs can develop Dourine. Different routes of 
infection, such as subcutaneous, intraperitoneal, intra-
venous, intraurethral and intravaginal transmission, 
were tested and all gave rise to clinical signs of Dou-
rine. In dogs, inoculation of T. equiperdum produces 
the typical picture of Dourine with trypanosomes 
present in the lesions, but not in the blood, and the in-
fection may last from one to several months (Stephen, 
1986; Claes, 2003).
Strains of T. equiperdum were successfully iso-
lated after intratesticular injection in the rabbit with 
blood or material from infected horses (Claes, 2003; 
Claes et al., 2005). Similarly, after the injection of ud-
der secretions from clinically diseased mares into the 
scrotum of rabbits, T. equiperdum could be isolated 
successfully from the scrotal tissue homogenate of the 
rabbit. The new isolate from that rabbit could also be 
re-isolated from scrotal edema of another rabbit af-
ter successive inoculation, even after freezing of the 
inoculum in liquid nitrogen (Pascucci et al., 2013). 
However, blood and genital washes from serologi-
cally positive horses did not lead to infection when 
inoculated into mice and puppies (Alemu et al., 1997; 
Hagos et al., 2010a; Pascucci et al., 2013). Attempts 
to transmit the parasite to animals other than horses 
(rats by intra peritoneal way and dogs subcutaneous-
ly) were also unsuccessful with inocula of blood and 
Cerebro Spinal Fluid (CSF) known to contain living 
trypanosomes (Barrowman, 1976). 
DNA-based technique 
A highly sensitive method for detecting even 
a single parasite is the polymerase chain reac-
tion (PCR) based on an amplification of trypano-
somal DNA with a sensitivity of 0.5 pg of parasite 
DNA or one single parasite in 10µl blood (Wuyts 
et al., 1994). Using PCR of a 135 bp portion of 
a highly repeated region within the Trypanozoon 
subgenus and the OVI strain of T. equiperdum as 
positive control was used by Pascucci et al. (2013) to 
detect the organism from blood and other tissue fluids 
such as uterine and vaginal washings, cerebrospi-
nal fluid, joint fluids, mammary secretion and urine. 
Moreover, solid tissues from udder, mammary and 
iliac lymph nodes, vulva, clitoris and uterus showed 
positive results for the parasite in Dourine affected 
animals. 
 
Serology: Indirect diagnosis
From earlier studies, it was known that the diagno-
sis of T. equiperdum by standard parasitological tech-
niques is difficult owing to the low numbers of para-
sites present in blood or tissue fluids and the frequent 
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absence of clinical signs of disease in the prepatent 
and the chronic phases. Consequently, the demonstra-
tion of trypanosomal antibodies in the serum has be-
come the most important diagnostic technique in de-
termining whether an animal is currently infected or 
has been previously in contact with the parasite (OIE, 
2013). Serological testing by the complement fixation 
test (CFT) has been widely used in health certification 
of horses for export (Wassal et al., 1991). 
Humoral antibodies are present in infected ani-
mals, whether they exhibit clinical signs or not. The 
CFT has been used to confirm clinical evidence and 
to detect latent infections (OIE, 2013). The reliability 
of CFT and IFAT for known T. equiperdum has been 
reported by Cauchard et al. (2014). However, unin-
fected equids, particularly donkeys and mules, often 
give inconsistent or nonspecific reactions because of 
the anti-complement effects of their sera. In this case, 
the indirect fluorescent antibody test (IFAT) is more 
adequate. Enzyme-linked immunosorbent assays 
(ELISAs) are also used (OIE, 2013). 
However, the diagnostic antigens and antibodies 
currently available for use in sero-diagnostic tests are 
not specific for T. equiperdum, but react due to the 
cross-reactivity with the other Trypanosome spp. Sig-
nificant improvements in Dourine sero-diagnosis will 
require the development of more specific T. equiper-
dum-subunit antigens. A recent publication reported 
the successful in vitro cultivation of T. equiperdum 
OVI parasites that can be used in complement fixation 
tests (Bassarak et al., 2016). This might be of great 
help in obtaining a specific diagnosis for T. equiper-
dum, since the OVI strain is one of the few genuine 
T. equiperdum strains generally available in reference 
laboratories (Claes et al., 2003b). Until all of these 
requirements have been achieved, however, the diag-
nosis of Dourine will of necessity involve the detailed 
history and the clinical and pathological findings, on 
top of the serology, to establish confirmation of the 
disease (Calistri et al., 2013). 
Because of the lack of a specific antigenic marker 
to differentiate T. equiperdum from T. evansi, careful 
attention must be paid when choosing a strain to pre-
pare such an antigen. According to recent data, true T. 
equiperdum needs to be differentiated from T. evansi 
(Claes et al., 2003a, b; 2004). The problem, however, 
is that many T. equiperdum strains have been found 
to be closely related to certain classes of T. evansi in 
cluster analysis by Random Amplified Polymorphic 
DNA (RAPD) and Multiplex-endonuclease genotyp-
ing (Claes et al., 2003b). With this in mind, the T. 
equiperdum Onderstepoort Veterinary Institute (OVI) 
and BoTat 1.1 strains have been found to be the most 
suitable for use as antigen sources. Single Nucleotide 
Polymorphism (SNP) within the F1-ATP synthase γ 
subunit gene provided an identifying characteristic 
of T. evansi as distinct from T. equiperdum without 
relying on VSG genes or kinetoplast DNA (Birhanu 
et al., 2016). A recent findings of whole genome SNP 
analysis of T. evansi and T. equiperdum also provided 
new insights in the origin of both species and their re-
lation with the different T. brucei subspecies (Cuypers 
et al., 2017). This method may be the future key for 
differentiation of the two species and then developing 
specific markers for diagnosis.  
Agglutination Test for Trypanosomosis 
Card and Latex agglutination tests developed for 
T. evansi from RoTat 1.2 antigen have been imple-
mented for Dourine diagnosis because of the cross-
reactive nature of the antibodies of some strains of 
T. equiperdum (Claes 2002). Fikru et al. (2010) and 
Hagos et al. (2010 a,b) have used the test to diagnose 
Dourine in Ethiopia at the field level. However, there 
is no RoTat1.2 gene on true T. equiperdum strains 
(Birhanu, et al. 2016; OIE, 2013). Therefore, unless 
genuine antigens are identified from true strains of T. 
equiperdum, these agglutination tests will be no more 
functional to diagnose Dourine (OIE, 2013).       
Indirect Fluorescent Antibody Test (IFAT)
The Indirect Fluorescent Antibody Test (IFAT) is 
frequently used in the diagnosis of Dourine as a con-
firmation test for a positive CFT result, since immuno- 
fluorescence is a more reliable and sensitive tech-
nique, though its interpretation is both subjective and 
labour intensive (Wiliamson et al., 1988). This test 
can be used in surveillance (prevalence of infection) 
and for the purpose of declaring a population free of 
the disease (OIE, 2013). This test has been used with 
success to diagnose Dourine in Italy (Pascucci et al., 
2013).
Enzyme-Linked Immunosorbent Assay (ELISA)
Although the CFT has been used for many years to 
diagnose Dourine, it is considered to be less sensitive 
than ELISA and it has been suggested that ELISA could 
replace the CFT for animal health certification. The 
Enzyme-Linked Immunosorbent Assay (ELISA) is a 
very sensitive technique and its use for routine diagnos- 
tic serology of Dourine would provide a significant 
advantage over current serological tests if a defined 
antigen were to be used, since it would permit test stan-
dardization and more readily allow comparison of the 
test results among the different laboratories. In addition, 
ELISA testing lends itself to a far greater degree of auto- 
mation, which makes it suitable for large numbers of 
samples (Wassal et al., 1991; Bishop et al., 1995).
Different authors have stated that the ELISA has 
a satisfactory concordance ratio with CFT and can 
be used to supplement CFT (Williamson et al., 1988; 
Alemu et al., 1997; Clausen et al., 2003). Similarly, 
Wasal et al. (1991) concluded that ELISA is a very 
sensitive test for Dourine compared to the CFT and 
IFA tests. 
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Recently, Davaasuren et al. (2017) have shown the 
use of ELISA to diagnose Dourine based on recombi-
nant GM6 antigen (rTeGM6) derived from T. equiper-
dum isolated from the urethral mucosa of a clinically 
Dourine diseased stallion in Mongolia (Suganuma et 
al., 2016). The result showed a good diagnostic value 
in testing the sera of T. equiperdum-infected horses. 
However, it has been already shown to diagnose T. 
evansi-infected water buffalo, cattle, goats and sheep 
(Nguyen et al., 2015; Nguyen et al., 2014) by this 
method. This might be helpful in the diagnosis of non-
tsetse transmitted horse trypanosomiases in the field, 
but the technique couldn’t differentiate between the 
two species.  
Genotype analysis is able to differentiate T. evansi 
from T. equiperdum (Carnes et al., 2015; Birhanu et 
al., 2016; Cuypers et al., 2017). This may lead to the 
development of other antigen-specific markers for T 
equiperdum in future ELISA.
TREATMENT
The World Organization for Animal Health (OIE, 
2013) currently imposes the slaughtering of CFT-posi- 
tive horses as an effective control strategy. In general, 
treatment may result in asymptomatic carrier animals 
and is as such not recommended in a Dourine-free 
territory because of fear for the continuing dissemi-
nation of the disease by the treated animals (Barrow-
man, 1976; Losos, 1986; OIE, 2000).
Evidence from in vitro drug sensitivity determina-
tion of T. equiperdum (Zhang et al., 1992; Brun and 
Lukins, 1994) indicates that Suramin, Diminazene, 
Quinapyramine and Cymelarsan are effective against 
trypanosome species. Hagos et al. (2010c) carried 
out in vivo efficacy testing of Diminazene diaceturate 
(Diminasan®) and bis (aminoethylthio) 4-melami-
nophenylarsine dihydrochloride (Cymelarsan®) on 
mice, which demonstrated that Cymelarsan® is ef-
fective, but that Diminasan®, on the other hand, fails 
even at high doses of up to 28 mg/kg body weight 
(four times the recommended dose in cattle) to cure 
any of the mice infected with the Dodola strain from 
Ethiopia.
Horses treated with Cymelarsan® at doses of 0.25 
mg/kg and 0.5 mg/kg body weight showed no detect-
able parasitaemia 24 h after treatment. The mean PCV 
levels also improved after treatment, and serorever-
sion on card agglutination test for trypanosoma was 
observed starting from 150 and 170 days post treat-
ment (Hagos et al., 2010c). This might have been due 
to the fact that the absence of the antigen source from 
the host system stopped the triggering of antibody 
production and consequently the antibodies were di-
luted in the serum. The study by Hagos et al. (2010c) 
showed improvement in body condition following the 
treatment of chronic infection and there was no re-
lapse. Moreover, the clinical signs of incoordination 
of the hind legs, weakness and ventral oedema dis-
appeared within 10 days, together with a progressive 
increase of the PCV. However, in recent reports, both 
Cymelarsan® and Diminasan® have been found to 
lead to relapse in treated mice (Habte et al., 2014), 
and parasites can still be found in the CSF of horses 
treated with Cymelarsan® (Cauchard et al., 2016). 
Recently, ex vivo trypanocidal activity of 1-(2-hy-
droxybenzylidene) thiosemicarbazide against Ven-
ezuelan T. equiperdum strain has been reported (Parra 
et al., 2017). The compound exhibits a greater inhibi-
tory activity of the parasite in the culture medium. 
In another recent report, in vitro laboratory tests of 
equine antimicrobial peptide (eCATH1) showed 
promising results relating to its trypanocidal activ-
ity on Trypanozoon spp through plasma membrane 
permeabilization and mitochondrial alteration. The 
administration of eCATH1 at a dose of 10 mg/kg to 
T. equiperdum-infected mice diminished the mortal-
ity rate. This finding suggests that eCATH1 can be 
considered as a candidate for the development of new 
therapeutic agents for the treatment of trypanosomo-
sis (Cauchard et al., 2016).
PROGNOSIS 
Horses treated with Cymelarsan showed elimi-
nation of the parasite from circulation within short 
periods of time (Hagos et al., 2010; Cauchard et al., 
2016). However, since the parasite is a tissue parasite, 
it may hide in areas that cannot easily be reached by 
the drugs, thus resulting in relapse (Cauchard et al., 
2016).
When horses are left untreated, the majority of 
cases will perish (Barrowman, 1976), or else they 
will develop a chronic form of Dourine with clinical 
signs as described above (Barrowman, 1976; Hagos 
et al., 2010a, c; Vulpiani et al., 2013). Parasitaemia 
may disappear after 80 days of infection even though 
the general body condition continues to progressively 
deteriorate (Barrowman, 1976; Hagos et al., 2010c). 
Infected animals became aparasitaemic after 80 days 
post infection, though they expressed parasitaemia 
again when challenged with immunosuppressive 
drugs (Hagos et al., 2010c). Therefore, it is assumed 
that the parasites can hide themselves from the im-
mune system.   
CONCLUSIONS 
Dourine is a contagious disease that is caused by 
T. equiperdum and is transmitted directly from ani-
mal to animal during coitus. It is a notifiable disease 
in most countries and it threatens equidae worldwide. 
Since knowledge about the prepatent infectiousness 
of semen is lacking, introduction of the disease is in 
principle an ever-present threat. Clinical signs of the 
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disease are very similar to Surra caused by T evansi. 
Differentiation of T. equiperdum and T. evansi in areas 
where the two organisms coexist remains a challenge 
due to the absence of a specific antigen and molecular 
marker for clinical use. Characterization of the true T. 
equiperdum strains and the search for specific genes 
should be the focus of future research. The World Or-
ganization for Animal Health (OIE) imposes euthana-
sia of diseased animals due to the absence of an effec-
tive treatment and to prevent the dissemination of the 
disease. However, in vitro anti-trypanosomal activity 
of thiosemicarbazide compounds and equine antimi-
crobial peptide (eCATH1) seems to be a promising 
approach in the context of future treatment strategies. 
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